Clinical Trial

AFFIX: Post-market Study of MaxTack™ Motorized Fixation Device in Subjects Undergoing Ventral Hernia Repair

Study acronym: AFFIX
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Medtronic is sponsoring and funding the AFFIX study, a prospective, post-market, multicenter, nonrandomized, single-arm, interventional clinical study. The purpose of this study is to evaluate the performance and safety of the MaxTack™ Motorized Fixation Device when used for fixation of prosthetic material to soft tissue in minimally invasive ventral hernia repair procedures.
Protocol Amendment History 4 changes
notable Primary completion pushed: 2026-03-23 -> 2026-07-28 2026-08-12
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-04-17
notable Enrollment reduced: 110 -> 35 participants 2026-04-17
minor Completion pushed: 2027-02-15 -> 2027-05-07 2026-04-17
Trial Details
NCT Number NCT06710795
Lead Sponsor Medtronic - MITG
Conditions Ventral Hernia
Enrollment 35 participants
Start Date 2025-06-16
Primary Completion 2026-07-28 (estimated)
Study Completion 2027-05-07 (estimated)
Updated on ClinicalTrials.gov 2026-08-11